Michael Morris, MD, MS
Dr. Morris has been treating cancer patients with radiopharmaceutical therapy for nearly ten years. His passion for excellence and commitment to patient care has made Chesapeake Theranostics a highly desirable choice for patients in the Baltimore and Washington region.

He’s also served as the Primary Investigator on FDA clinical trials of all phases, and helped with expanding access for patients in community practice settings that use emerging radiopharmaceutical therapy and molecular imaging techniques. Dr. Morris has given presentations at national and international scientific conferences and is the author of multiple peer-reviewed articles in the fields of nuclear medicine, diagnostic radiology, and clinical informatics.